Table 3 Treatment outcomes for patients associated with molecular marker status
Patient | Gender | Smoking status | EGFR status | ERCC1 | RRM1 | CR | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Biopsy | SS | Pre-Pl | Post-Pl | mRNA | IHC | mRNA | IHC | Â |
1 | M | Current | Wild | Ex19 Del | Wild | Wild | + | (−) | +++ | (+) | PR |
2 | F | Never | Wild | / | Wild | / | / | / | / | / | SD |
3 | F | Never | Wild | / | Wild | / | / | / | / | / | SD |
4 | M | Current | / | Wild | Wild | Wild | + | (−) | +++ | (−) | SD |
5 | F | Never | Wild | Wild | Wild | Wild | + | (−) | +++ | (−) | PR |
6 | F | Never | Wild | Wild | Wild | Wild | + | (−) | +++ | (+) | PR |
7 | F | Never | Wild | / | Wild | / | / | / | / | / | SD |
8 | F | Never | Ex19 Del | Ex19 Del | Wild | Wild | + | (−) | +++ | (+) | PR |
9 | M | Current | Wild | / | Wild | / | / | / | / | / | PD |
10 | M | Current | Ex19 Del | Ex19 Del | Wild | Wild | ++ | (−) | ++ | (−) | PR |
11 | M | Former | / | / | Wild | / | / | / | / | / | SD |